Option Care Health (NASDAQ:OPCH) Research Coverage Started at JMP Securities

JMP Securities began coverage on shares of Option Care Health (NASDAQ:OPCH) in a research report sent to investors on Tuesday, Marketbeat Ratings reports. The firm issued an outperform rating and a $36.00 price target on the stock.

Separately, Barrington Research reaffirmed an outperform rating and issued a $38.00 price target on shares of Option Care Health in a research report on Wednesday, April 24th.

Option Care Health Stock Performance

Shares of Option Care Health stock opened at $30.33 on Tuesday. The business has a 50-day moving average of $28.80 and a 200 day moving average of $30.81. Option Care Health has a 12 month low of $26.11 and a 12 month high of $35.74. The stock has a market capitalization of $5.27 billion, a price-to-earnings ratio of 19.95, a price-to-earnings-growth ratio of 1.50 and a beta of 1.24. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.77 and a quick ratio of 1.39.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings results on Tuesday, April 23rd. The company reported $0.26 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.22 by $0.04. The company had revenue of $1.15 billion for the quarter, compared to analyst estimates of $1.10 billion. Option Care Health had a return on equity of 18.92% and a net margin of 6.15%. Option Care Health’s revenue for the quarter was up 12.8% compared to the same quarter last year. During the same quarter last year, the company earned $0.21 EPS. As a group, sell-side analysts forecast that Option Care Health will post 1.19 earnings per share for the current year.

Institutional Investors Weigh In On Option Care Health

Several hedge funds and other institutional investors have recently made changes to their positions in OPCH. American Century Companies Inc. raised its position in shares of Option Care Health by 7.4% during the 3rd quarter. American Century Companies Inc. now owns 990,729 shares of the company’s stock worth $32,050,000 after acquiring an additional 68,138 shares in the last quarter. Vanguard Group Inc. increased its position in Option Care Health by 11.8% during the third quarter. Vanguard Group Inc. now owns 19,319,352 shares of the company’s stock worth $624,981,000 after buying an additional 2,037,162 shares during the period. Dfpg Investments LLC acquired a new position in Option Care Health during the fourth quarter worth approximately $225,000. Advisor Resource Council acquired a new position in Option Care Health during the fourth quarter worth approximately $304,000. Finally, Raymond James & Associates increased its position in Option Care Health by 200.9% during the fourth quarter. Raymond James & Associates now owns 50,047 shares of the company’s stock worth $1,686,000 after buying an additional 33,414 shares during the period. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.